Healthcare provider profile · identity verified

David J. Paris, M.D.

Family Practice · FORT WAYNE, IN · NPI 1134110430

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1087	298
Amlodipine Besylate	Amlodipine Besylate	663	183
Metoprolol Succinate	Metoprolol Succinate	459	132
Levothyroxine Sodium	Levothyroxine Sodium	418	99
Omeprazole	Omeprazole	365	98
Lisinopril	Lisinopril	302	78
Metformin Hcl	Metformin Hcl	290	80
Losartan Potassium	Losartan Potassium	234	72
Pantoprazole Sodium	Pantoprazole Sodium	225	63
Tamsulosin Hcl	Tamsulosin Hcl	217	62
Eliquis	Apixaban	205	60
Furosemide	Furosemide	194	66
Famotidine	Famotidine	177	60
Rosuvastatin Calcium	Rosuvastatin Calcium	175	51
Hydrochlorothiazide	Hydrochlorothiazide	170	47
Carvedilol	Carvedilol	162	51
Clopidogrel	Clopidogrel Bisulfate	162	40
Simvastatin	Simvastatin	154	43
Alendronate Sodium	Alendronate Sodium	140	39
Pravastatin Sodium	Pravastatin Sodium	134	33
Trazodone Hcl	Trazodone Hcl	133	40
Fluticasone Propionate	Fluticasone Propionate	131	47
Gabapentin	Gabapentin	126	49
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	125	33
Meloxicam	Meloxicam	123	49
Glipizide Er	Glipizide	120	36
Albuterol Sulfate Hfa	Albuterol Sulfate	118	62
Atenolol	Atenolol	118	32
Ezetimibe	Ezetimibe	116	34
Allopurinol	Allopurinol	106	38
Finasteride	Finasteride	106	34
Sertraline Hcl	Sertraline Hcl	104	32
Methylprednisolone	Methylprednisolone	102	78
Valsartan	Valsartan	100	30
Tramadol Hcl	Tramadol Hcl	97	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	90	26
Citalopram Hbr	Citalopram Hydrobromide	89	25
Montelukast Sodium	Montelukast Sodium	87	29
Azithromycin	Azithromycin	82	67
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	74	18
Isosorbide Mononitrate Er	Isosorbide Mononitrate	71	20
Metoprolol Tartrate	Metoprolol Tartrate	69	23
Escitalopram Oxalate	Escitalopram Oxalate	68	22
Warfarin Sodium	Warfarin Sodium	65	17
Fluoxetine Hcl	Fluoxetine Hcl	62	17
Xarelto	Rivaroxaban	59	17
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	58	42
Potassium Chloride	Potassium Chloride	57	18
Synthroid	Levothyroxine Sodium	57	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	56	19
Spironolactone	Spironolactone	53	22
Alprazolam	Alprazolam	52	13
Triamcinolone Acetonide	Triamcinolone Acetonide	52	28
Farxiga	Dapagliflozin Propanediol	49	15
Lorazepam	Lorazepam	47	16
Esomeprazole Magnesium	Esomeprazole Magnesium	46	14
Clonazepam	Clonazepam	45	14
Acyclovir	Acyclovir	43	12
Buspirone Hcl	Buspirone Hcl	43	13
Bupropion Xl	Bupropion Hcl	41	15
Trulicity	Dulaglutide	41	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	24
Ozempic	Semaglutide	39	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	37	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	36	suppressed
Duloxetine Hcl	Duloxetine Hcl	36	12
Januvia	Sitagliptin Phosphate	36	suppressed
Propranolol Hcl Er	Propranolol Hcl	36	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	35	11
Sumatriptan Succinate	Sumatriptan Succinate	34	suppressed
Benazepril Hcl	Benazepril Hcl	33	suppressed
Mirtazapine	Mirtazapine	33	suppressed
Clonidine Hcl	Clonidine Hcl	32	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	31	suppressed
Bumetanide	Bumetanide	31	suppressed
Nitroglycerin	Nitroglycerin	30	24
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	30	suppressed
Amoxicillin	Amoxicillin	27	14
Breo Ellipta	Fluticasone/Vilanterol	27	suppressed
Diclofenac Sodium	Diclofenac Sodium	27	12
Donepezil Hcl	Donepezil Hcl	26	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	26	24
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	25	suppressed
Jardiance	Empagliflozin	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	25	suppressed
Fenofibrate	Fenofibrate	24	suppressed
Lamotrigine	Lamotrigine	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Chlorthalidone	Chlorthalidone	23	suppressed
Propranolol Hcl	Propranolol Hcl	23	suppressed
Symbicort	Budesonide/Formoterol Fumarate	23	11
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	22	suppressed
Metformin Hcl Er	Metformin Hcl	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Levofloxacin	Levofloxacin	20	16
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Cephalexin	Cephalexin	18	17
Dutasteride	Dutasteride	18	suppressed
Mounjaro	Tirzepatide	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	17	13
Doxycycline Monohydrate	Doxycycline Monohydrate	17	15
Memantine Hcl	Memantine Hcl	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	17
Lovastatin	Lovastatin	16	suppressed
Prolia	Denosumab	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	11
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	14	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	14	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	13
Nystatin	Nystatin	14	suppressed
Amlodipine-Atorvastatin	Amlodipine/Atorvastatin	13	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Mupirocin	Mupirocin	12	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error